Skip to content
healthcare.dev

Carbamazepine ER

NDC 72516-021, Carbamazepine, tablet, extended release, from Oryza Pharmaceuticals Inc..

Product NDC
72516-021
Status
Listed
Labeler
Oryza Pharmaceuticals Inc.
Dosage form
TABLET, EXTENDED RELEASE
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA212948
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/72516-021 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • CARBAMAZEPINE400 mg/1

Pharmacologic classes

Cytochrome P450 1A2 Inducers [MoA]; Cytochrome P450 2B6 Inducers [MoA]; Cytochrome P450 2C19 Inducers [MoA]; Cytochrome P450 2C9 Inducers [MoA]; Cytochrome P450 3A4 Inducers [MoA]; Decreased Central Nervous System Disorganized Electrical Activity [PE]; Mood Stabilizer [EPC]

Package NDCNDC-11Package
72516-021-0172516002101100 TABLET, EXTENDED RELEASE in 1 BOTTLE (72516-021-01)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/34b375d0-68b0-4bd5-8ac9-be043b57e91c
  • NADAC price for package 72516002101

    GET /v1/drugs/nadac/72516002101

Use it

Look up 72516-021 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/72516-021 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 72516-021. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.